EA
USNA icon

Emerald Acquisition’s Usana Health Sciences USNA Stock Holding History

Emerald Acquisition’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.64M Sell
23,670
-59,226
-71% -$3.91M ﹤0.01% 1856
2016
Q2 		$4.62M Buy
+82,896
New +$5M 0.01% 1374

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Emerald Acquisition's USNA Position: Q3 2016 in Review

Emerald Acquisition reduced its Usana Health Sciences (USNA) stake by 71% in Q3 2016, selling an estimated $3.91M and leaving 23,670 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Emerald Acquisition first reported a position in USNA in Q2 2016 and has held it in 2 quarters since. The position peaked at $4.62M in Q2 2016. 140 funds tracked by Wall St. Rank hold USNA as of Q3 2016.

  • Emerald Acquisition held 23,670 shares of Usana Health Sciences worth $1.64M as of Q3 2016.
  • Emerald Acquisition sold 59,226 Usana Health Sciences shares in Q3 2016, an estimated $3.91M.
  • Usana Health Sciences made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1856 holding.
  • Emerald Acquisition first reported a position in Usana Health Sciences in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Usana Health Sciences position peaked at $4.62M in Q2 2016.
  • 140 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.